Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyBiologicalProcess	synaptic membrane adhesion	MDGA2 ELFN2 TENM3 ELFN1 SLITRK5	1.39e-05	42	152	5	GO:0099560
GeneOntologyCellularComponent	microtubule organizing center	ANKRD62 CDH23 ALPK1 SPECC1 CLIP1 RASSF7 ABRAXAS2 NEK1 HAUS4 EYS KIF2B NDC80 STARD9 CROCC2 SASS6 CEP152 G6PD DCTN3	1.08e-04	919	150	18	GO:0005815
GeneOntologyCellularComponent	centrosome	ANKRD62 CDH23 ALPK1 CLIP1 RASSF7 ABRAXAS2 NEK1 HAUS4 EYS KIF2B NDC80 CROCC2 SASS6 CEP152 G6PD DCTN3	1.36e-04	770	150	16	GO:0005813
GeneOntologyCellularComponent	kinetochore	CLIP1 KIF2B NDC80 ARID2 BUB1 KNL1 DCTN3	3.38e-04	181	150	7	GO:0000776
GeneOntologyCellularComponent	photoreceptor connecting cilium	MYO7A PCDHB13 PCDHB8 ALPK1	3.88e-04	48	150	4	GO:0032391
GeneOntologyCellularComponent	microtubule	TTLL8 CLIP1 ABRAXAS2 HAUS4 EML5 KIF2B DNAH17 MACF1 EIF3A DNAI7 DNAH5 DCTN3	4.76e-04	533	150	12	GO:0005874
GeneOntologyCellularComponent	condensed chromosome, centromeric region	CLIP1 KIF2B NDC80 ARID2 BUB1 KNL1 DCTN3	4.97e-04	193	150	7	GO:0000779
GeneOntologyCellularComponent	outer kinetochore	NDC80 BUB1 KNL1	6.56e-04	24	150	3	GO:0000940
GeneOntologyCellularComponent	axonemal dynein complex	DNAH17 DNAI7 DNAH5	7.42e-04	25	150	3	GO:0005858
GeneOntologyCellularComponent	procentriole replication complex	SASS6 CEP152	7.53e-04	6	150	2	GO:0120099
GeneOntologyCellularComponent	deuterosome	SASS6 CEP152	7.53e-04	6	150	2	GO:0098536
GeneOntologyCellularComponent	microtubule associated complex	HAUS4 KIF2B DNAH17 DNAI7 DNAH5 DCTN3	1.09e-03	161	150	6	GO:0005875
Domain	ARM-type_fold	RALGAPA1 USP34 SMG1 CLTCL1 MROH2A VEPH1 XPO4 HEATR1 TRIP12 ARID2 AP4B1	6.54e-05	339	144	11	IPR016024
Domain	BTB	PATZ1 RCBTB2 KLHL11 IBTK RHOBTB1 RCBTB1 RHOBTB2	7.04e-05	131	144	7	PF00651
Domain	BTB	PATZ1 RCBTB2 KLHL11 IBTK RHOBTB1 RCBTB1 RHOBTB2	2.44e-04	160	144	7	PS50097
Domain	SH3_domain	KALRN MYO7A MYO7B ITK SH3BP4 SRGAP3 MACF1 FYB2	3.12e-04	220	144	8	IPR001452
Domain	RCC1	RCBTB2 IBTK RCBTB1	4.65e-04	20	144	3	PF00415
Domain	BTB	PATZ1 RCBTB2 KLHL11 IBTK RHOBTB1 RCBTB1 RHOBTB2	4.98e-04	180	144	7	SM00225
Domain	RCC1_1	RCBTB2 IBTK RCBTB1	5.39e-04	21	144	3	PS00625
Domain	RCC1_2	RCBTB2 IBTK RCBTB1	5.39e-04	21	144	3	PS00626
Domain	RCC1_3	RCBTB2 IBTK RCBTB1	5.39e-04	21	144	3	PS50012
Domain	BTB/POZ_dom	PATZ1 RCBTB2 KLHL11 IBTK RHOBTB1 RCBTB1 RHOBTB2	5.87e-04	185	144	7	IPR000210
Domain	FCH	PSTPIP2 SRGAP3 FER	6.21e-04	22	144	3	PF00611
Domain	-	RCBTB2 IBTK RCBTB1	6.21e-04	22	144	3	2.130.10.30
Domain	Reg_chr_condens	RCBTB2 IBTK RCBTB1	6.21e-04	22	144	3	IPR000408
Domain	FCH	PSTPIP2 SRGAP3 FER	6.21e-04	22	144	3	SM00055
Domain	SKP1/BTB/POZ	PATZ1 RCBTB2 KLHL11 IBTK RHOBTB1 RCBTB1 RHOBTB2	6.66e-04	189	144	7	IPR011333
Domain	FCH_dom	PSTPIP2 SRGAP3 FER	7.10e-04	23	144	3	IPR001060
Domain	RCC1/BLIP-II	RCBTB2 IBTK RCBTB1	7.10e-04	23	144	3	IPR009091
Domain	F_BAR	PSTPIP2 SRGAP3 FER	9.12e-04	25	144	3	IPR031160
Domain	F_BAR	PSTPIP2 SRGAP3 FER	9.12e-04	25	144	3	PS51741
Domain	Kinase-like_dom	SMG1 MYLK PDGFRA KALRN ALPK1 ITK STRADB NEK1 BUB1 FER MACF1 ALK	1.02e-03	542	144	12	IPR011009
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	TRAF7 USP34 DDX31 SPART AASDH NUP58 HAUS4 IGF2BP3 NDC80 ARID2 BUB1 SASS6 MACF1 CFAP44 GOLGB1 KNL1	9.06e-09	588	154	16	38580884
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	PRUNE2 ANKRD62 ALPK1 ELFN2 EFTUD2 ABRAXAS2 NEK1 RHOBTB1 ARID2 DNAH17 SLITRK5 MACF1 CEP152 EIF3A	4.75e-08	493	154	14	15368895
Pubmed	Docking motif-guided mapping of the interactome of protein phosphatase-1.	DDX31 VPS54 ELFN2 ELFN1 MARF1 DNAI7 KNL1	7.05e-08	80	154	7	19389623
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	RALGAPA1 PDGFRA PATZ1 ALPK1 SPECC1 TRIP12 RASSF7 ITK TAB3 SH3BP4 CDCA2 FSIP2 NEK1 STARD9 MACF1 CEP152 GOLGB1	3.08e-07	861	154	17	36931259
Pubmed	An organelle-specific protein landscape identifies novel diseases and molecular mechanisms.	EXOC6 MYO7A CALR PATZ1 UBE3B XPO4 CDH23 HEATR1 CLIP1 AKAP12 SH3BP4 EFTUD2 NEK1 HAUS4 EML5 BUB1 MARF1 UCK2 CCAR2 FYB2 DCTN3	4.19e-07	1321	154	21	27173435
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	ZFYVE16 SPART HEATR1 AKAP12 EFTUD2 IBTK NEK1 IGF2BP3 UBAP2L ABCE1 ARID2 MACF1 PRR14L EIF3A G6PD GOLGB1 KNL1	9.46e-07	934	154	17	33916271
Pubmed	Identification of motif-based interactions between SARS-CoV-2 protein domains and human peptide ligands pinpoint antiviral targets.	KALRN PATZ1 QRICH1 AKAP12 GUCY1A2 UBAP2L STARD9 UNKL EIF3A	1.06e-06	233	154	9	37704626
Pubmed	Interrogating the protein interactomes of RAS isoforms identifies PIP5K1A as a KRAS-specific vulnerability.	STX8 AHCYL1 CALR SLC6A15 VPS54 SPECC1 AKAP12 IGF2BP3 SLITRK5 MACF1 STX7 GOLGB1	1.28e-06	467	154	12	30194290
Pubmed	The proximal proteome of 17 SARS-CoV-2 proteins links to disrupted antiviral signaling and host translation.	STX8 ZFYVE16 CALR STRBP VPS13C SPART SLC6A15 VPS54 AKAP12 EFTUD2 NEK1 NDC80 SLITRK5 CCAR2 EIF3A STX7 GOLGB1	2.61e-06	1007	154	17	34597346
Pubmed	Systematic analysis of human protein complexes identifies chromosome segregation proteins.	CALR SPECC1 CLIP1 PPL AKAP12 EFTUD2 TGM1 HAUS4 IGF2BP3 NDC80 ARID2 BUB1 SASS6 CCAR2 CEP152 EIF3A KNL1 DCTN3	3.96e-06	1155	154	18	20360068
Pubmed	Expression of testicular germ cell genes identified by differential display analysis.	ANKRD20A3P ANKRD20A4P ANKRD20A1	4.69e-06	8	154	3	12634303
Pubmed	A germline-specific class of small RNAs binds mammalian Piwi proteins.	UBE3B PIWIL1 EMILIN2 HEATR1 SPECC1 ELFN2 AKAP12 FSIP2 MTF1 RHOBTB2 CATSPERG	5.77e-06	450	154	11	16751776
Pubmed	DNA sequence and analysis of human chromosome 9.	PRUNE2 DDX31 STRBP ANKRD20A2P ADAMTS13 ANKRD20A3P CER1 ANKRD20A4P ANKRD20A1 DCTN3	6.50e-06	370	154	10	15164053
Pubmed	Comparative host-coronavirus protein interaction networks reveal pan-viral disease mechanisms.	RALGAPA1 TRAF7 CALR SPART XPO4 SLC6A15 HEATR1 NUP58 IBTK UBAP2L RCBTB1 EIF3A GOLGB1 IGHV3-72	7.24e-06	754	154	14	33060197
Pubmed	Protein interaction domain mapping of human kinetochore protein Blinkin reveals a consensus motif for binding of spindle assembly checkpoint proteins Bub1 and BubR1.	NDC80 BUB1 KNL1	9.99e-06	10	154	3	21199919
Pubmed	Defining the proximal interaction networks of Arf GTPases reveals a mechanism for the regulation of PLD1 and PI4KB.	USP34 VPS13C SLC6A15 TRIP12 PPL AKAP12 SH3BP4 EFTUD2 CDCA2 IGF2BP3 TENM3 SLITRK5 CCAR2 GOLGB1	1.01e-05	777	154	14	35844135
Pubmed	Identifying biological pathways that underlie primordial short stature using network analysis.	CALR STRBP HEATR1 NUP58 SPECC1 TRIP12 EFTUD2 IGF2BP3 UBAP2L FUBP1 MACF1 UCK2 CCAR2 EIF3A STX7 GOLGB1	1.36e-05	1024	154	16	24711643
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: II. The complete nucleotide sequences of 400 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	ZFYVE16 PXDN TENM3 UBAP2L SRGAP3 STARD9 RHOBTB2 MACF1 CCAR2 TRAK2	1.48e-05	407	154	10	12693553
Pubmed	C5orf51 is a component of the MON1-CCZ1 complex and controls RAB7A localization and stability during mitophagy.	RALGAPA1 STX8 ZFYVE16 VPS13C DEF8 SLC6A15 AKAP12 SH3BP4 STARD3 STX7 GOLGB1	1.66e-05	504	154	11	34432599
Pubmed	G6PD overexpression protects from oxidative stress and age-related hearing loss.	CDH23 G6PD	1.95e-05	2	154	2	33222382
Pubmed	Progressive hearing loss and increased susceptibility to noise-induced hearing loss in mice carrying a Cdh23 but not a Myo7a mutation.	MYO7A CDH23	1.95e-05	2	154	2	14648237
Pubmed	[Usher type I syndrome in children: genotype/phenotype correlation and cochlear implant benefits].	MYO7A CDH23	1.95e-05	2	154	2	18323324
Pubmed	Cdh23 mutations in the mouse are associated with retinal dysfunction but not retinal degeneration.	MYO7A CDH23	1.95e-05	2	154	2	14609561
Pubmed	Mutation analysis of the MYO7A and CDH23 genes in Japanese patients with Usher syndrome type 1.	MYO7A CDH23	1.95e-05	2	154	2	20844544
Pubmed	DBC2, a candidate for a tumor suppressor gene involved in breast cancer.	RHOBTB2 CCAR2	1.95e-05	2	154	2	12370419
Pubmed	Effect of KNL1 on the proliferation and apoptosis of colorectal cancer cells.	BUB1 KNL1	1.95e-05	2	154	2	31315522
Pubmed	The crystal structure of the N-terminal region of BUB1 provides insight into the mechanism of BUB1 recruitment to kinetochores.	BUB1 KNL1	1.95e-05	2	154	2	19141287
Pubmed	Differential roles of syntaxin 7 and syntaxin 8 in endosomal trafficking.	STX8 STX7	1.95e-05	2	154	2	10564279
Pubmed	The extracellular leucine-rich repeat superfamily; a comparative survey and analysis of evolutionary relationships and expression patterns.	ELFN2 ELFN1	1.95e-05	2	154	2	17868438
Pubmed	Expression of CLLD7 and CHC1L Proteins in Oral Epithelial Dysplasia in a Group of Thai Patients.	RCBTB2 RCBTB1	1.95e-05	2	154	2	38679985
Pubmed	Differential expression of surface markers in mouse bone marrow mesenchymal stromal cell subpopulations with distinct lineage commitment.	PDGFRA CD200	1.95e-05	2	154	2	23236457
Pubmed	IGF2BP3-mediated enhanced stability of MYLK represses MSC adipogenesis and alleviates obesity and insulin resistance in HFD mice.	MYLK IGF2BP3	1.95e-05	2	154	2	38196046
Pubmed	Differential palmitoylation of the endosomal SNAREs syntaxin 7 and syntaxin 8.	STX8 STX7	1.95e-05	2	154	2	18980942
Pubmed	Stereocilia defects in waltzer (Cdh23), shaker1 (Myo7a) and double waltzer/shaker1 mutant mice.	MYO7A CDH23	1.95e-05	2	154	2	12121736
Pubmed	In-Depth In Vivo Crosslinking in Minutes by a Compact, Membrane-Permeable, and Alkynyl-Enrichable Crosslinker.	SMG1 AHCYL1 CLTCL1 MYLK STRBP MAFA HEATR1 TRIP12 PPL CDCA2 PXDN GUCY1A2 STARD9 FUBP1 MARF1 MACF1 CCAR2 EIF3A GOLGB1	2.24e-05	1442	154	19	35575683
Pubmed	Inner centromere formation requires hMis14, a trident kinetochore protein that specifically recruits HP1 to human chromosomes.	NDC80 BUB1 KNL1	2.99e-05	14	154	3	20231385
Pubmed	Identifications of novel host cell factors that interact with the receptor-binding domain of the SARS-CoV-2 spike protein.	SMG1 AHCYL1 STRBP UBE3B SH3BP4 KLHL11 IBTK ABCE1 BUB1 MARF1 STARD3 AP4B1	3.53e-05	650	154	12	38777146
Pubmed	BioID reveals an ATG9A interaction with ATG13-ATG101 in the degradation of p62/SQSTM1-ubiquitin clusters.	PRUNE2 STX8 ZFYVE16 SLC6A15 VPS54 ABCE1 SLITRK5 AP4B1	4.28e-05	285	154	8	34369648
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	IBTK NEK1 IGF2BP3 MACF1 CEP152 EIF3A TRAK2	4.31e-05	209	154	7	36779422
Pubmed	New roles for the de-ubiquitylating enzyme OTUD4 in an RNA-protein network and RNA granules.	RALGAPA1 EXOC6 STRBP IGF2BP3 UBAP2L FUBP1 STARD3 UCK2 CCAR2 UNKL	4.34e-05	462	154	10	31138677
Pubmed	A ubiquitin-based effector-to-inhibitor switch coordinates early brain, craniofacial, and skin development.	RCBTB2 KLHL11 RHOBTB1 RCBTB1 DNAH5	4.40e-05	87	154	5	37495603
Pubmed	Novel asymmetrically localizing components of human centrosomes identified by complementary proteomics methods.	CLIP1 NEK1 HAUS4 SASS6 CEP152 DCTN3	4.98e-05	146	154	6	21399614
Pubmed	Multiple assembly mechanisms anchor the KMN spindle checkpoint platform at human mitotic kinetochores.	NDC80 KNL1	5.83e-05	3	154	2	25601404
Pubmed	Sequential multisite phospho-regulation of KNL1-BUB3 interfaces at mitotic kinetochores.	BUB1 KNL1	5.83e-05	3	154	2	25661489
Pubmed	The Dictyostelium discoideum family of Rho-related proteins.	RHOBTB1 RHOBTB2	5.83e-05	3	154	2	11222756
Pubmed	Expanding the PP2A Interactome by Defining a B56-Specific SLiM.	CDCA2 BUB1	5.83e-05	3	154	2	27998540
Pubmed	Differential distribution of harmonin isoforms and their possible role in Usher-1 protein complexes in mammalian photoreceptor cells.	MYO7A CDH23	5.83e-05	3	154	2	14578428
Pubmed	Structural analysis reveals features of the spindle checkpoint kinase Bub1-kinetochore subunit Knl1 interaction.	BUB1 KNL1	5.83e-05	3	154	2	22331848
Pubmed	Atypical Rho GTPases of the RhoBTB Subfamily: Roles in Vesicle Trafficking and Tumorigenesis.	RHOBTB1 RHOBTB2	5.83e-05	3	154	2	27314390
Pubmed	Restoration of compact Golgi morphology in advanced prostate cancer enhances susceptibility to galectin-1-induced apoptosis by modifying mucin O-glycan synthesis.	GCNT1 GOLGB1	5.83e-05	3	154	2	25086069
Pubmed	Genomic organization and expression profile of the small GTPases of the RhoBTB family in human and mouse.	RHOBTB1 RHOBTB2	5.83e-05	3	154	2	12426103
Pubmed	Genetic analysis through OtoSeq of Pakistani families segregating prelingual hearing loss.	MYO7A CDH23	5.83e-05	3	154	2	23770805
Pubmed	MPS1/Mph1 phosphorylates the kinetochore protein KNL1/Spc7 to recruit SAC components.	BUB1 KNL1	5.83e-05	3	154	2	22660415
Pubmed	Stereociliary myosin-1c receptors are sensitive to calcium chelation and absent from cadherin 23 mutant mice.	MYO7A CDH23	5.83e-05	3	154	2	17050716
Pubmed	Survey of the frequency of USH1 gene mutations in a cohort of Usher patients shows the importance of cadherin 23 and protocadherin 15 genes and establishes a detection rate of above 90%.	MYO7A CDH23	5.83e-05	3	154	2	16679490
Pubmed	Cadherin-23, myosin VIIa and harmonin, encoded by Usher syndrome type I genes, form a ternary complex and interact with membrane phospholipids.	MYO7A CDH23	5.83e-05	3	154	2	20639393
Pubmed	The anatomy and development of the mutants pirouette, shaker-1 and waltzer in the mouse.	MYO7A CDH23	5.83e-05	3	154	2	13336002
Pubmed	Complex N-glycosylation of mGluR6 is required for trans-synaptic interaction with ELFN adhesion proteins.	ELFN2 ELFN1	5.83e-05	3	154	2	38428819
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	PRUNE2 USP34 SMG1 ALPK1 SRGAP3 RHOBTB2 MACF1	6.86e-05	225	154	7	12168954
Pubmed	Functional proteomics mapping of a human signaling pathway.	SMG1 ZFYVE16 SPART QRICH1 TRIP12 PPL ABRAXAS2 TENM3 MACF1 GOLGB1 KNL1	7.00e-05	591	154	11	15231748
Pubmed	The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a pluripotency sub-network that includes DPPA4, a regulator of embryogenesis.	TRAF7 USP34 PATZ1 SPECC1 CLIP1 JARID2 IBTK SASS6 CCAR2	7.29e-05	396	154	9	26687479
Pubmed	Liganded ERα Stimulates the E3 Ubiquitin Ligase Activity of UBE3C to Facilitate Cell Proliferation.	PATZ1 TAB3 NDC80	7.83e-05	19	154	3	26389696
Pubmed	Gene Expression by Mouse Inner Ear Hair Cells during Development.	MYO7A CDH23 DNAH5	7.83e-05	19	154	3	25904789
Pubmed	A human skeletal muscle interactome centered on proteins involved in muscular dystrophies: LGMD interactome.	GPD1 SMG1 KALRN SPART CLIP1 TCAP AKAP12 STRADB MACF1 EIF3A	7.96e-05	497	154	10	23414517
Pubmed	A high-throughput approach for measuring temporal changes in the interactome.	PRUNE2 USP34 AHCYL1 CALR MC1R QRICH1 CLIP1 AKAP12 EFTUD2 ABRAXAS2 IGF2BP3 ABCE1 FUBP1 MACF1 CCAR2 EIF3A G6PD DCTN3	8.36e-05	1455	154	18	22863883
Pubmed	Prediction of the coding sequences of unidentified human genes. VIII. 78 new cDNA clones from brain which code for large proteins in vitro.	SMG1 NUP58 SRGAP3 MARF1	8.48e-05	52	154	4	9455477
Pubmed	USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.	MYO7B TRIP12 EFTUD2 IGF2BP3 MACF1 DNAH5 GOLGB1	8.76e-05	234	154	7	36243803
Pubmed	Analysis of interaction partners for eukaryotic translation elongation factor 1A M-domain by functional proteomics.	ANKRD62 DNAH17 MACF1	9.18e-05	20	154	3	21689717
Pubmed	Protein interactome mining defines melatonin MT1 receptors as integral component of presynaptic protein complexes of neurons.	USP34 CALR TRIP12 TENM3 UBAP2L MARF1 MACF1 EIF3A	1.00e-04	322	154	8	26514267
Pubmed	Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis.	CLTCL1 MYO7A CLIP1 EFTUD2 ABRAXAS2 IGF2BP3 NDC80 FUBP1 MACF1 CCAR2 EIF3A GOLGB1 DCTN3	1.08e-04	847	154	13	35235311
Pubmed	Physical and functional interaction between protocadherin 15 and myosin VIIa in mechanosensory hair cells.	MYO7A CDH23	1.16e-04	4	154	2	16481439
Pubmed	PDGFR blockade is a rational and effective therapy for NPM-ALK-driven lymphomas.	PDGFRA ALK	1.16e-04	4	154	2	23064464
Pubmed	Validation study of genetic associations with coronary artery disease on chromosome 3q13-21 and potential effect modification by smoking.	MYLK KALRN	1.16e-04	4	154	2	19706030
Pubmed	Syntaxin 7, syntaxin 8, Vti1 and VAMP7 (vesicle-associated membrane protein 7) form an active SNARE complex for early macropinocytic compartment fusion in Dictyostelium discoideum.	STX8 STX7	1.16e-04	4	154	2	12175335
Pubmed	The two-pore channel TPC1 is required for efficient protein processing through early and recycling endosomes.	STX8 STX7	1.16e-04	4	154	2	28855648
Pubmed	Jarid2 is induced by TCR signalling and controls iNKT cell maturation.	ITK JARID2	1.16e-04	4	154	2	25105474
Pubmed	Defining the molecular basis of BubR1 kinetochore interactions and APC/C-CDC20 inhibition.	BUB1 KNL1	1.16e-04	4	154	2	20220147
Pubmed	A sequential multi-target Mps1 phosphorylation cascade promotes spindle checkpoint signaling.	BUB1 KNL1	1.16e-04	4	154	2	28072388
Pubmed	Phosphoproteomic analysis of the developing mouse brain.	USP34 CLIP1 AKAP12 NEK1 IGF2BP3 CCAR2 STX7	1.19e-04	246	154	7	15345747
Pubmed	Ex vivo Quantitative Proteomic Analysis of Serotonin Transporter Interactome: Network Impact of the SERT Ala56 Coding Variant.	RALGAPA1 VPS13C SPECC1 ELFN2 ELFN1 SRGAP3 STARD9 MACF1 SYT5	1.36e-04	430	154	9	32581705
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	PARVB QRICH1 ITPA SH3BP4 JARID2 IGF2BP3 TENM3 RCBTB1 ARID2 CEP152	1.47e-04	536	154	10	15840001
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	PARVB QRICH1 ITPA SH3BP4 JARID2 IGF2BP3 TENM3 RCBTB1 ARID2 CEP152	1.52e-04	538	154	10	10512203
Pubmed	The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis.	EXOC6 DDX31 STRBP HEATR1 TRIP12 CDCA2 IBTK IGF2BP3 UBAP2L ARID2 MACF1 CCAR2	1.52e-04	759	154	12	35915203
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	USP34 DDX31 CALR STRBP HEATR1 TRIP12 IGF2BP3 UBAP2L ABCE1 MACF1 CCAR2	1.68e-04	653	154	11	22586326
Pubmed	Characterization of RhoBTB-dependent Cul3 ubiquitin ligase complexes--evidence for an autoregulatory mechanism.	RHOBTB1 RHOBTB2	1.93e-04	5	154	2	18835386
Pubmed	Role of CLASP2 in microtubule stabilization and the regulation of persistent motility.	CLIP1 MACF1	1.93e-04	5	154	2	17113391
Pubmed	Interactions in the network of Usher syndrome type 1 proteins.	MYO7A CDH23	1.93e-04	5	154	2	15590703
Pubmed	Cochlear outer hair cells undergo an apical circumference remodeling constrained by the hair bundle shape.	MYO7A CDH23	1.93e-04	5	154	2	20332152
Pubmed	Characterization of Usher syndrome type I gene mutations in an Usher syndrome patient population.	MYO7A CDH23	1.93e-04	5	154	2	15660226
Pubmed	Physical and functional characterization of the genetic locus of IBtk, an inhibitor of Bruton's tyrosine kinase: evidence for three protein isoforms of IBtk.	ITK IBTK	1.93e-04	5	154	2	18596081
Pubmed	Dissecting the roles of human BUB1 in the spindle assembly checkpoint.	BUB1 KNL1	1.93e-04	5	154	2	26148513
Pubmed	Lateral to end-on conversion of chromosome-microtubule attachment requires kinesins CENP-E and MCAK.	KIF2B NDC80	1.93e-04	5	154	2	23891108
Pubmed	The human microcephaly protein STIL interacts with CPAP and is required for procentriole formation.	SASS6 CEP152	1.93e-04	5	154	2	22020124
Pubmed	Molecular and functional analyses of the human and mouse genes encoding AFG3L1, a mitochondrial metalloprotease homologous to the human spastic paraplegia protein.	MC1R DEF8	1.93e-04	5	154	2	11549317
Pubmed	Usher syndrome type I G (USH1G) is caused by mutations in the gene encoding SANS, a protein that associates with the USH1C protein, harmonin.	MYO7A CDH23	1.93e-04	5	154	2	12588794
Pubmed	Usher I syndrome: unravelling the mechanisms that underlie the cohesion of the growing hair bundle in inner ear sensory cells.	MYO7A CDH23	1.93e-04	5	154	2	16219682
Pubmed	Digenic inheritance of deafness caused by 8J allele of myosin-VIIA and mutations in other Usher I genes.	MYO7A CDH23	1.93e-04	5	154	2	22381527
Pubmed	Myosin VIIa, harmonin and cadherin 23, three Usher I gene products that cooperate to shape the sensory hair cell bundle.	MYO7A CDH23	1.93e-04	5	154	2	12485990
Pubmed	TRIP12 ubiquitination of glucocerebrosidase contributes to neurodegeneration in Parkinson's disease.	VPS13C CDH23 TRIP12 CFAP44	2.28e-04	67	154	4	34644545
Pubmed	A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.	USP34 SMG1 STX8 CLTCL1 CALR STRBP XPO4 HEATR1 SPECC1 EFTUD2 IGF2BP3 PXDN UBAP2L CCAR2 EIF3A STX7 G6PD	2.31e-04	1440	154	17	30833792
Interaction	ANKRD20A4P interactions	ANKRD20A2P ANKRD20A4P ANKRD20A1	7.95e-06	6	150	3	int:ANKRD20A4P
Interaction	ANKRD20A2P interactions	ANKRD20A2P ANKRD20A4P ANKRD20A1	1.38e-05	7	150	3	int:ANKRD20A2P
GeneFamily	Armadillo repeat containing\|Protein phosphatase 1 regulatory subunits	AHCYL1 DDX31 ZFYVE16 VPS54 ELFN2 CDCA2 ELFN1 MARF1 FER DNAI7 KNL1	4.88e-09	181	100	11	694
GeneFamily	Basic leucine zipper proteins\|BTB domain containing	PATZ1 RCBTB2 KLHL11 IBTK RHOBTB1 RCBTB1 RHOBTB2	9.47e-06	134	100	7	861
GeneFamily	A-kinase anchoring proteins\|Myosins, class VII\|Deafness associated genes\|FERM domain containing	MYO7A MYO7B	3.03e-05	2	100	2	1102
GeneFamily	Rho GTPase activating proteins\|F-BAR domain containing	PSTPIP2 SRGAP3 FER	2.68e-04	23	100	3	1288
GeneFamily	Blood group antigens\|CD molecules\|I-set domain containing\|Immunoglobulin like domain containing	TMIGD1 MYLK PDGFRA KALRN MDGA2 PXDN	2.72e-04	161	100	6	593
GeneFamily	EF-hand domain containing\|Plakins	PPL MACF1	8.30e-04	8	100	2	939
GeneFamily	Ankyrin repeat domain containing	ANKRD62 ANKRD20A2P ANKRD20A3P IBTK ANKRD20A4P ANKRD20A1	2.26e-03	242	100	6	403
GeneFamily	AT-rich interaction domain containing	JARID2 ARID2	3.03e-03	15	100	2	418
GeneFamily	StAR related lipid transfer domain containing	STARD9 STARD3	3.03e-03	15	100	2	759
GeneFamily	Syntaxins	STX8 STX7	3.46e-03	16	100	2	818
GeneFamily	Dyneins, axonemal	DNAH17 DNAH5	3.90e-03	17	100	2	536
GeneFamily	Rho family GTPases	RHOBTB1 RHOBTB2	5.39e-03	20	100	2	390
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	USP34 EXOC6 STX8 PDGFRA XPO4 VPS54 HEATR1 NUP58 GCNT1 AKAP12 IBTK UBAP2L ABCE1 FUBP1 FER ETAA1 CEP152 CD200	6.32e-07	776	152	18	M1107
Coexpression	GRAESSMANN_RESPONSE_TO_MC_AND_DOXORUBICIN_DN	USP34 EXOC6 STX8 PDGFRA XPO4 VPS54 HEATR1 NUP58 GCNT1 AKAP12 IBTK UBAP2L ABCE1 FUBP1 FER ETAA1 CEP152 CD200	8.78e-07	794	152	18	MM982
Coexpression	HOOI_ST7_TARGETS_DN	EXOC6 CLIP1 PPL SRGAP3 ARID2 DNAH5 ALK	4.98e-06	115	152	7	M14801
Coexpression	GSE19888_ADENOSINE_A3R_ACT_VS_A3R_ACT_WITH_A3R_INH_PRETREATMENT_IN_MAST_CELL_DN	TMIGD1 MC1R CDH23 ZNF385B TAB3 IBTK UNKL CD200	2.21e-05	199	152	8	M7332
Coexpression	GSE40666_UNTREATED_VS_IFNA_STIM_STAT4_KO_EFFECTOR_CD8_TCELL_90MIN_DN	VPS13C GCNT1 JARID2 STRADB P2RY14 TRAK2 STX7 CD200	2.21e-05	199	152	8	M9236
Coexpression	GSE39556_UNTREATED_VS_3H_POLYIC_INJ_MOUSE_CD8A_DC_DN	RALGAPA1 MYLK ZFYVE16 AKAP12 PXDN STARD3 P2RY14 KDSR	2.29e-05	200	152	8	M9408
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	USP34 ZFYVE16 SPART GCNT1 TRIP12 CLIP1 JARID2 IBTK NEK1 IGF2BP3 NDC80 ABCE1 FUBP1 MACF1 UCK2 EIF3A	3.98e-05	856	152	16	M4500
ToppCell	3'_v3-bone_marrow-Lymphocytic_B-Pro-B\|bone_marrow / Manually curated celltypes from each tissue	MYLK MYO7B STRBP MAFA PXDN SLITRK5 CD200	1.17e-06	156	153	7	b093dbba6662e4fffc8aa577587b77f64ac44b56
ToppCell	CV-Severe-7\|CV / Virus stimulation, Condition and Cluster	SMG1 KALRN CALR HEATR1 ITK ARID2 P2RY14	2.61e-06	176	153	7	3de0c7d77210049e5616db21eed1490a17a5ec2d
ToppCell	3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MYLK IGHV3-11 ANKRD62 GUCY1A2 STARD9 P2RY14 RCAN2	2.71e-06	177	153	7	452ec2df36c6d656a7cdadc55be545ccdb146a29
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Epithelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7A SH3BP4 TENM3 DNAI7 CFAP44 DNAH5 KLKB1	2.81e-06	178	153	7	6178706db4a855d72abc156537604d575624df56
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Epithelial-nan\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYO7A SH3BP4 TENM3 DNAI7 CFAP44 DNAH5 KLKB1	2.81e-06	178	153	7	f02076ece0fa899e620971c887ad4da7f48684ed
ToppCell	10x5'-bone_marrow-Hematopoietic_Erythro-Mega-Megakaryocyte_early\|bone_marrow / Manually curated celltypes from each tissue	MYLK PDGFRA KALRN VEPH1 PARVB IGF2BP3 PROS1	3.37e-06	183	153	7	3cc9f3dc3bc4bde1d3408b0a6ba58e135a11036d
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-5\|TCGA-Liver / Sample_Type by Project: Shred V9	TMIGD1 CDCA2 IGF2BP3 NDC80 FUBP1 BUB1 G6PD	3.37e-06	183	153	7	f604a8b62c7088fad8365dbf8d910fc980bd3ba8
ToppCell	COPD-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P SPECC1 SH3BP4 ANKRD20A4P P2RY14 ANKRD20A1	3.50e-06	184	153	7	42d7ce104cd7bcb83fbbbd0e7d3267ad07edfa94
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYLK PDGFRA VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	3.76e-06	186	153	7	3bf38c80d892a73391009b426dec8ae26a027351
ToppCell	PBMC-Control-Hematopoietic-Platelet\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYLK PDGFRA VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	3.76e-06	186	153	7	7496137cebc191aecd1e6ae7fa33118b128fbfe6
ToppCell	PBMC-Control-Hematopoietic-Platelet\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYLK PDGFRA VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	3.76e-06	186	153	7	9c2fd0bbc968c317a763f52e72fa7182c3c49850
ToppCell	IPF-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P SPECC1 SH3BP4 ANKRD20A4P P2RY14 ANKRD20A1	3.76e-06	186	153	7	962c2dada19185628ead77c32fcb07fa95114247
ToppCell	PBMC-Control-Hematopoietic-Platelet-Platelet\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYLK PDGFRA VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	3.76e-06	186	153	7	06281df5e9665ccc510279bf7e552845c63d5dab
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D150\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	MDGA2 THSD7B GUCY1A2 STARD9 SLITRK5 P2RY14 RCAN2	3.89e-06	187	153	7	fa01a61bfd13feb033ba1e35cf513707b1bff8c8
ToppCell	10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8\|GI_small-bowel / Manually curated celltypes from each tissue	RALGAPA1 USP34 SMG1 VPS13C ARID2 MACF1 GOLGB1	4.03e-06	188	153	7	ab9b725d6e0cdab8e9ddda6dee09e14730e9a578
ToppCell	IPF-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P SPECC1 SH3BP4 ANKRD20A4P P2RY14 ANKRD20A1	4.03e-06	188	153	7	47bb6caf84f70a1cda7d09803afdfd5182772e66
ToppCell	IPF-Myeloid-cDC1\|IPF / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P SPECC1 SH3BP4 ANKRD20A4P P2RY14 ANKRD20A1	4.03e-06	188	153	7	2331a2bae1383820d598e93aa86c75b101069bac
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK KALRN GUCY1A2 ELFN1 SYT5 P2RY14 RCAN2	4.17e-06	189	153	7	de51fbd6fdb24fc4549393cf41a020005444b2aa
ToppCell	10x_3'_v3-thymus_(10x_3'_v3)-lymphocytic-B_lymphocytic-naive_B_cell\|thymus_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	MYO7B STRBP VPS13C GCNT1 P2RY14 STX7 CD200	4.17e-06	189	153	7	e2bb5900d210386b7b74938e7a3636d0c7ba1bcf
ToppCell	Healthy-Platelet\|Healthy / disease group, cell group and cell class	MYLK PDGFRA VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	4.17e-06	189	153	7	5863e132536594e49bffbb637454cc43dfdbaa20
ToppCell	droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-smooth_muscle_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK KALRN GUCY1A2 ELFN1 SYT5 P2RY14 RCAN2	4.32e-06	190	153	7	1d8e169d2448a34180c415843bb49aa45ed540c5
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal-Deuterosomal_L.0.3.4.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZNF487 STRBP CROCC2 SYT5 CEP152 DNAI7 KNL1	4.32e-06	190	153	7	0adb24dafa077156bbc73a8d8cbf3d9eeb6e08df
ToppCell	3'-Airway_Nasal-Epithelial-Airway_ciliated-multi-ciliated_epithelial_cell-Deuterosomal\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ZNF487 STRBP CROCC2 SYT5 CEP152 DNAI7 KNL1	4.32e-06	190	153	7	05455775845f4ded5c27e7b83242078d23162aaf
ToppCell	COPD-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P SPECC1 SH3BP4 ANKRD20A4P P2RY14 ANKRD20A1	4.47e-06	191	153	7	3480e6d27dd4291765bbbb2acdb6a2e4f02c8085
ToppCell	COPD-Myeloid-cDC1\|COPD / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P SPECC1 SH3BP4 ANKRD20A4P P2RY14 ANKRD20A1	4.63e-06	192	153	7	bd3d00b094d92463b06023361a71240851a542b8
ToppCell	Mild/Remission-B_naive-11\|Mild/Remission / disease group and sub_cluster of B and Plasma cells(res = 0.5)	STRBP VPS13C SPART GCNT1 P2RY14 STX7 CD200	4.63e-06	192	153	7	c6f325cddce43b72f013b21dfffc9987fd68b6a7
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK PDGFRA SPECC1 AKAP12 GUCY1A2 TENM3 RCAN2	4.95e-06	194	153	7	90efdbd7f1c85fd7fd622b10340250b1d8fc1197
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK PDGFRA SPECC1 AKAP12 GUCY1A2 TENM3 RCAN2	4.95e-06	194	153	7	df82cce5ebeb73740b02cf816c6df82253cfd566
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Mesenchymal-Fibroblast\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	MYLK PDGFRA SPECC1 AKAP12 GUCY1A2 TENM3 RCAN2	5.30e-06	196	153	7	2b36b9a40fe415917afccff99ad9c3474e087d0d
ToppCell	Parenchymal-NucSeq-Immune_Myeloid-Macrophage_other-Macro_AW_CX3CR1\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MYO7A EMILIN2 PARVB GCNT1 S100Z CDCA2 BUB1	5.66e-06	198	153	7	732a43061d75bc5e1cf23f5056b72cd10c926668
ToppCell	mild-Platelet\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYLK PDGFRA VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	5.66e-06	198	153	7	91ae3cc261d23ec3aa7656bbf3f13dcbfee262d2
ToppCell	control-Platelet\|control / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYLK PDGFRA VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	5.66e-06	198	153	7	1a4b604ef25bd066e870c0d00ee31cde9617f125
ToppCell	severe-Platelet\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	MYLK PDGFRA VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	5.85e-06	199	153	7	6539c197c653fce083a893ac422263abbbc07e79
ToppCell	18-Airway-Mesenchymal-Mesenchyme_RSPO2+\|Airway / Age, Tissue, Lineage and Cell class	MYLK AKAP12 CDCA2 NDC80 BUB1 MACF1 KNL1	5.85e-06	199	153	7	7ac35e8f45dcdc702422dabd8f3e4d03e2bf61af
ToppCell	Control-Control-Others\|Control / Disease, condition lineage and cell class	MYLK PDGFRA VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	5.85e-06	199	153	7	b7e83772fdd466e1bd0ae13af9ac477e7595ae14
ToppCell	TCGA-Stomach-Primary_Tumor\|TCGA-Stomach / Sample_Type by Project: Shred V9	DDX31 HEATR1 EFTUD2 NDC80 UBAP2L ABCE1 BUB1	5.85e-06	199	153	7	38f1f612b29feb868322999ceeda78e52447ec4f
ToppCell	Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	PRUNE2 MYLK KALRN AKAP12 PXDN GUCY1A2 RCAN2	5.85e-06	199	153	7	b1753474152b82a0b811b9878c890a359e14919a
ToppCell	TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma\|TCGA-Stomach / Sample_Type by Project: Shred V9	DDX31 HEATR1 EFTUD2 NDC80 UBAP2L ABCE1 BUB1	5.85e-06	199	153	7	b10698aee2e6c17bc559eb4f723024141f914b90
ToppCell	LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB\|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type	MYLK PDGFRA ALPK1 AKAP12 SLITRK5 MACF1 RCAN2	6.05e-06	200	153	7	9b0916d8d07ac2bf1739f7be5296bf77ffee6094
ToppCell	Transverse-(7)_Mast_cell-(70)_Mast\|Transverse / shred on region, Cell_type, and subtype	EMILIN2 LXN SPECC1 AKAP12 FER P2RY14 PROS1	6.05e-06	200	153	7	aa17354c83b0967707d995e4b74e042ac211f814
ToppCell	Transverse-Mast_cell-Mast\|Transverse / Region, Cell class and subclass	EMILIN2 LXN SPECC1 AKAP12 FER P2RY14 PROS1	6.05e-06	200	153	7	0af942a33cc50da65129204976e24203320e206d
ToppCell	Transverse-Mast_cell\|Transverse / Region, Cell class and subclass	EMILIN2 LXN SPECC1 AKAP12 FER P2RY14 PROS1	6.05e-06	200	153	7	5e3f5349ffbcabdca3d911fbc99a46aaa56c47c4
ToppCell	mild\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	USP34 SMG1 VPS13C TRIP12 MACF1 EIF3A GOLGB1	6.05e-06	200	153	7	12f1685ce8f218433068e090c9d839cd5a1910bf
ToppCell	Control-Control-Others-Platelet\|Control / Disease, condition lineage and cell class	MYLK PDGFRA VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	6.05e-06	200	153	7	e0463c93714ab5fd00f294cca83bd61027fe0e95
ToppCell	Transverse-(7)_Mast_cell\|Transverse / shred on region, Cell_type, and subtype	EMILIN2 LXN SPECC1 AKAP12 FER P2RY14 PROS1	6.05e-06	200	153	7	d90d1d3015a9258298bd6b4ba07971aa1af8b82b
ToppCell	E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3\|E16.5-samps / Age Group, Lineage, Cell class and subclass	MYLK RCBTB2 EFTUD2 NEK1 NDC80 BUB1	1.29e-05	149	153	6	651494e84be03dc7b061ebdfa91756a1c507b9b4
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_E\|343B / Donor, Lineage, Cell class and subclass (all cells)	RALGAPA1 DDX31 KALRN SRGAP3 CCAR2 UNKL	1.73e-05	157	153	6	0362c04b7b0b5017964b3a73ee678ae53e7238d7
ToppCell	RV-13._Vascular_Smooth_Muscle\|RV / Chamber and Cluster_Paper	PRUNE2 MYLK KALRN SPECC1 AKAP12 GUCY1A2	2.00e-05	161	153	6	47b3b7662cbb671ccc086dc0a0cabd65f63eb5a1
ToppCell	LPS-antiTNF-Endothelial-Endothelial-FOXM1\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PIWIL1 CDCA2 NDC80 BUB1 SASS6 KNL1	2.14e-05	163	153	6	5285318c52aa31c9b22dc2ffff078e32e408604d
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPL CDCA2 NDC80 BUB1 CEP152 DNAH5	2.22e-05	164	153	6	4307b002fb41ddfc7ab8a6bca66a60942c250052
ToppCell	LPS-antiTNF-Epithelial_airway-Mes-Epi-like-Airway\|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PPL CDCA2 NDC80 BUB1 CEP152 DNAH5	2.22e-05	164	153	6	1d84aa5b925f502ee9c5fa39714490f613a58028
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRUNE2 MYLK AASDH TCAP SLITRK5 RCAN2	2.38e-05	166	153	6	390cf5e56b72fcaf3b8520930bd35a3e3e173711
ToppCell	PND01-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC\|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PRUNE2 MYLK AASDH TCAP SLITRK5 RCAN2	2.38e-05	166	153	6	9a341dc7b756252caeaac1e934384911c880a634
ToppCell	droplet-Thymus-nan-24m-Lymphocytic-DN_to_DP_transition,_dividing_(more_DN)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SDR42E1 PARVB ELFN2 SRGAP3 FER G6PD	2.54e-05	168	153	6	b9db0b1e4fe54a1fe79530d15d206155a1bfac39
ToppCell	Dividing_Macrophages-Donor_08\|World / lung cells shred on cell class, cell subclass, sample id	ANKRD20A2P CDCA2 NDC80 SASS6 CEP152 KNL1	2.63e-05	169	153	6	eb0c993ef2eea73bc4881182520922ce9ae9368f
ToppCell	renal_medulla_nuclei-Adult_normal_reference-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_3\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	PRUNE2 PPL FSIP2 SRGAP3 DNAH17 CD200	2.72e-05	170	153	6	5d5f208682be21ed58320f5fc083a7898f8712da
ToppCell	droplet-Skin-nan-18m-Epithelial-keratinocyte_stem_cell\|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PRUNE2 PDGFRA KALRN SLITRK5 DNAI7 KLKB1	2.72e-05	170	153	6	10e0912dd0beab5d0bbe2bd49e477b5962687925
ToppCell	facs-Trachea-18m-Hematologic-myeloid-granulocyte-granulocyte_l26\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	GCNT1 PSTPIP2 LXN P2RY14 KDSR FYB2	2.72e-05	170	153	6	4b1c84b35b7242a297ffdb9c23a6d982acf1bed5
ToppCell	LV-13._Vascular_Smooth_Muscle\|LV / Chamber and Cluster_Paper	PRUNE2 MYLK KALRN SPECC1 CER1 GUCY1A2	2.81e-05	171	153	6	e99ecae66530d1ae09330cee408c8f3950b87e67
ToppCell	PND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PDGFRA CDCA2 NDC80 BUB1 P2RY14 KNL1	3.09e-05	174	153	6	7b2f35add804981c7d588a996bdbca6ec11a1ca5
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_E\|NK_cells / Donor, Lineage, Cell class and subclass (all cells)	RALGAPA1 DDX31 KALRN SRGAP3 CCAR2 UNKL	3.20e-05	175	153	6	78a86cac3e6c0d115c997d1c29ee0e24af54551f
ToppCell	droplet-Lung-3m-Hematologic-myeloid-myeloid_dendritic_cell-proliferating_dendritic\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	NUP58 IL1RL2 CDCA2 BUB1 RCAN2 KNL1	3.30e-05	176	153	6	581045e61cdcdfa85701343d1a7c0a72a36606a7
ToppCell	5'-Adult-Appendix-Mesenchymal-myocytic-myofibroblast\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MYLK PXDN RHOBTB1 STARD9 P2RY14 RCAN2	3.41e-05	177	153	6	e65c0568dc5852108e9802273499bc7cf88fafab
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYLK PDGFRA VEPH1 PARVB RHOBTB1 PROS1	3.63e-05	179	153	6	510927794bbd21814eba75286e0801eb1fd2e8a6
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYLK PDGFRA VEPH1 PARVB RHOBTB1 PROS1	3.63e-05	179	153	6	906a5ebbbac660b6fd498ced09d0ada40a3e64af
ToppCell	LPS-IL1RA-Endothelial-Endothelial-FOXM1\|LPS-IL1RA / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	PIWIL1 CDCA2 NDC80 BUB1 CEP152 KNL1	3.74e-05	180	153	6	334e2b1f6eb7d4ece20b1c7b02107863f913237f
ToppCell	Control-Fibroblasts-Airway_smooth_muscle\|Control / group, cell type (main and fine annotations)	PRUNE2 MYLK KALRN THSD7B AKAP12 RCAN2	3.74e-05	180	153	6	d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1
ToppCell	megakaryocytic-Platelet\|World / Lineage and Cell class	MYLK PDGFRA VEPH1 OVOS2 IGF2BP3 PROS1	3.74e-05	180	153	6	c007c3e63c2bb35ed34327dd8863899b5db93115
ToppCell	RA-07._Pericyte\|RA / Chamber and Cluster_Paper	KALRN THSD7B SPECC1 GUCY1A2 P2RY14 RCAN2	3.86e-05	181	153	6	8dfb42d096db6c2df9b41303a7199d134d4bff07
ToppCell	10x5'-Liver-Lymphocytic_T_CD4-T_CD4/CD8\|Liver / Manually curated celltypes from each tissue	RALGAPA1 USP34 SMG1 ITK ARID2 MACF1	3.86e-05	181	153	6	f2315414e714ac86211546a935660c4be6e85f1b
ToppCell	droplet-Marrow-nan-3m-Myeloid-nan\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 VPS13C PSTPIP2 CLIP1 AKAP12 MACF1	3.98e-05	182	153	6	f8c73baaaca145e2efc48f10f636feb79c8fc779
ToppCell	3'_v3-bone_marrow-Hematopoietic_Erythro-Mega-Megakaryocyte_early\|bone_marrow / Manually curated celltypes from each tissue	MYLK PDGFRA VEPH1 IGF2BP3 RHOBTB1 PROS1	3.98e-05	182	153	6	1a755ea44daf8447a3a1c30de7fdb9c3888bcbde
ToppCell	PCW_05-06-Neuronal-Neuronal_SCP-neuro_proliferating_SCP2_(1)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	MDGA2 GCNT1 CDCA2 NDC80 BUB1 ALK	3.98e-05	182	153	6	f7f9be9c7ef8da9864d6aefe20043b26e1bb8697
ToppCell	cellseq-Epithelial-Epithelial_Airway-Ciliated/Deuterosomal-Deuterosomal\|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	STRBP CROCC2 BUB1 SYT5 CEP152 DNAI7	3.98e-05	182	153	6	deb53a4f84e4cd5c3b4180a4ac43249da9d738f7
ToppCell	18-Airway-Epithelial-Multiciliated_precursor\|Airway / Age, Tissue, Lineage and Cell class	ANKRD20A4P DNAH17 SYT5 CEP152 DNAI7 ANKRD20A1	4.10e-05	183	153	6	a75cda2131755931117c387f2e0ae3394efa8e80
ToppCell	facs-Heart-RA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SPECC1 GUCY1A2 CCAR2 SYT5 P2RY14	4.10e-05	183	153	6	0f02136359787bd78146617990968baa47a65d86
ToppCell	facs-Heart-RA-18m-Mesenchymal-valve_cell\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MYLK SPECC1 GUCY1A2 CCAR2 SYT5 P2RY14	4.10e-05	183	153	6	2f0dcc65ad4d90ef946919b4462280fdd20c5ea0
ToppCell	Control-Myeloid-cDC1\|Myeloid / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P SPECC1 ANKRD20A4P P2RY14 ANKRD20A1	4.23e-05	184	153	6	c6affa0b12510363258f65e46bf2d47bf4a8e75f
ToppCell	droplet-Marrow-nan-3m\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SMG1 VPS13C CLIP1 AKAP12 MACF1 EIF3A	4.23e-05	184	153	6	1154a5ad7b8512272b7476f949ddac350910bfb7
ToppCell	Control-immature_Neutrophil-\|Control / Disease condition and Cell class	STRBP SPART HEATR1 ANKRD20A4P BUB1 KNL1	4.23e-05	184	153	6	c4e8ba82a6aa76c46f05a71d5f1c7926555318cf
ToppCell	Control-immature_Neutrophil\|Control / Disease condition and Cell class	STRBP SPART HEATR1 ANKRD20A4P BUB1 KNL1	4.23e-05	184	153	6	2fdae5c6b3eb2232881d933a8c1061fda3623016
ToppCell	LPS_only-Epithelial_alveolar-AT_2-AT1-AT2\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	MROH2A SDR42E1 ZNF385B PPL EML5	4.26e-05	112	153	5	456278fb92dd41820fde8cf27c68fec45e15f972
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYLK PDGFRA KALRN VEPH1 PSTPIP2 IGF2BP3	4.36e-05	185	153	6	709236097cbfc254796fcc69b5f5178b73dad9bd
ToppCell	PBMC-Convalescent-Hematopoietic-Platelet-Platelet-plt_4\|Convalescent / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MYLK PDGFRA KALRN VEPH1 PSTPIP2 IGF2BP3	4.36e-05	185	153	6	af078a6c4a3e0b54b7d8ab7b30dcd06053ebfd28
ToppCell	Control-T_cells-Cycling_NK/T_cells\|Control / group, cell type (main and fine annotations)	CDCA2 IGF2BP3 NDC80 BUB1 CEP152 KNL1	4.36e-05	185	153	6	9766216b41ee62bbac4caa25cb98ec5627a24075
ToppCell	PBMC-Control-Hematopoietic\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MYLK VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	4.36e-05	185	153	6	c95c77d4302d7fff7fdef1774f15a93ba9ced61a
ToppCell	Multiple_Sclerosis-Other-Platelet\|Multiple_Sclerosis / Disease, Lineage and Cell Type	MYLK PDGFRA PARVB IGF2BP3 RHOBTB1 PROS1	4.36e-05	185	153	6	2e480dde7ecb2f88ff005f86ef732a1cf0209d45
ToppCell	PBMC-Control-Hematopoietic\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MYLK VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	4.36e-05	185	153	6	72a281ef246de5b30de1241d792c25bfae60e797
ToppCell	megakaryocytic-Megakaryocyte\|World / Lineage and Cell class	MYLK KALRN OVOS2 PARVB PSTPIP2 PROS1	4.49e-05	186	153	6	acd15a169b6122b28cc99ef34de10701edcfedfe
ToppCell	Control-Myeloid-cDC1\|World / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P SPECC1 ANKRD20A4P P2RY14 ANKRD20A1	4.49e-05	186	153	6	3de803dee3ef10eb85a2b47d3f93385214e5b0ff
ToppCell	Control-Myeloid-cDC1\|Control / Disease state, Lineage and Cell class	ANKRD20A2P ANKRD20A3P SPECC1 ANKRD20A4P P2RY14 ANKRD20A1	4.49e-05	186	153	6	b05c394aa3573ba855abc3066739ca193883b0c3
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CDCA2 GUCY1A2 TENM3 NDC80 BUB1 KNL1	4.63e-05	187	153	6	e41e39fd3791acf8ae5376cc5061e196d96868ae
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Cycling_Myofibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	CDCA2 GUCY1A2 TENM3 NDC80 BUB1 KNL1	4.63e-05	187	153	6	cefa211ef224e803ea9467882e2ca74d0b1492f1
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MDGA2 THSD7B SPECC1 GUCY1A2 STARD9 RCAN2	4.63e-05	187	153	6	48bfdb3504c3fefe5db3abac4b790c369680ab4e
ToppCell	Control-Hematopoietic_Mega-Platelet\|Control / Disease group, lineage and cell class	MYLK VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	4.63e-05	187	153	6	53e9665e1feb02ce8fe78ff4128fd4beacef8471
ToppCell	Control-Hematopoietic_Mega\|Control / Disease group, lineage and cell class	MYLK VEPH1 PARVB IGF2BP3 RHOBTB1 PROS1	4.63e-05	187	153	6	7bf98bdc83feb3918dbcf12e87a64fe4d2d41eba
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	MDGA2 THSD7B SPECC1 GUCY1A2 STARD9 RCAN2	4.63e-05	187	153	6	958402fcc78f4c7a7d13d659d776f3817137975f
ToppCell	Fetal_29-31_weeks-Mesenchymal-pericyte_cell-D062\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ANKRD62 MDGA2 GUCY1A2 STARD9 P2RY14 RCAN2	4.77e-05	188	153	6	ccddc08121caff958a2b6f9e278a018858af6b4d
ToppCell	droplet-Kidney-nan-3m-Epithelial-Epcam____podocyte-2\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	VEPH1 RASSF7 PPL AKAP12 TENM3 RCAN2	4.77e-05	188	153	6	c300accbac71a3bc075fe985543d8a8ead82531b
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF-SCMF_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	PDGFRA CDCA2 NDC80 BUB1 P2RY14 KNL1	4.77e-05	188	153	6	95d0a796d62ce6d121e2028c378faffc14b35275
Disease	MICROCEPHALY 4, PRIMARY, AUTOSOMAL RECESSIVE	CEP152 KNL1	2.47e-05	2	147	2	C1858516
Disease	developmental and epileptic encephalopathy 64 (implicated_via_orthology)	RHOBTB1 RHOBTB2	2.47e-05	2	147	2	DOID:0070375 (implicated_via_orthology)
Disease	acute graft vs. host disease, donor genotype effect measurement	KALRN MDGA2 EYS	5.28e-05	15	147	3	EFO_0004599, EFO_0007892
Disease	Autosomal recessive primary microcephaly	SASS6 CEP152 KNL1	5.28e-05	15	147	3	cv:C3711387
Disease	disease recurrence, colon carcinoma	ZNF777 THSD7B GUCY1A2 MACF1	1.23e-04	51	147	4	EFO_0004952, EFO_1001950
Disease	Autosomal Recessive Primary Microcephaly	SASS6 CEP152 KNL1	1.74e-04	22	147	3	C3711387
Disease	PR interval	KALRN UBE3B EMILIN2 XPO4 SLC6A15 NDC80 ARID2 FER MACF1 RCAN2	1.98e-04	495	147	10	EFO_0004462
Disease	Usher syndrome, type 1A	MYO7A CDH23	2.44e-04	5	147	2	C2931205
Disease	USHER SYNDROME, TYPE IB (disorder)	MYO7A CDH23	2.44e-04	5	147	2	C1848638
Disease	USHER SYNDROME, TYPE IA, FORMERLY	MYO7A CDH23	2.44e-04	5	147	2	C1848639
Disease	USHER SYNDROME, TYPE I, FRENCH VARIETY, FORMERLY	MYO7A CDH23	2.44e-04	5	147	2	C1848640
Disease	Usher syndrome type 1	MYO7A CDH23	2.44e-04	5	147	2	cv:C1568247
Disease	Usher Syndrome, Type I	MYO7A CDH23	3.65e-04	6	147	2	C1568247
Disease	Hereditary retinal dystrophy	MYO7A CDH23	5.09e-04	7	147	2	C0154860
Disease	Usher syndrome	MYO7A CDH23	5.09e-04	7	147	2	cv:C0271097
Disease	cocaine use disorder, social environment measurement	STRADB TRAK2	6.77e-04	8	147	2	EFO_0010445, EFO_0010552
Disease	hepatocellular carcinoma (is_marker_for)	TRAF7 CALR EFTUD2 ABCE1 FUBP1 ARID2 G6PD	8.09e-04	301	147	7	DOID:684 (is_marker_for)
Disease	triglyceride change measurement, response to simvastatin, response to fenofibrate	SLC6A15 TTLL8 RHOBTB1	8.31e-04	37	147	3	EFO_0007681, GO_1901557, GO_1903491
Disease	anemia (phenotype), response to ribavirin	ITPA DNAH17	8.67e-04	9	147	2	EFO_0004272, GO_1901559
Disease	plasma renin activity measurement	TENM3 KLKB1	8.67e-04	9	147	2	EFO_0006828
Disease	lifestyle measurement, systolic blood pressure	KALRN CDCA2	8.67e-04	9	147	2	EFO_0006335, EFO_0010724
Disease	response to radiation	EMILIN2 PSTPIP2 IGF2BP3 DNAH5	9.97e-04	88	147	4	GO_0009314
Disease	body height at birth	EXOC6 STRBP IGF2BP3	1.05e-03	40	147	3	EFO_0006784
Disease	melanoma	PDGFRA MYO7A MC1R PCDHB8 LXN ALK	1.56e-03	248	147	6	C0025202
Disease	Anemia, Hemolytic, Acquired	ITPA G6PD	1.85e-03	13	147	2	C0002879
Disease	Anemia, Hemolytic	ITPA G6PD	1.85e-03	13	147	2	C0002878
Disease	Anemia, Microangiopathic	ITPA G6PD	1.85e-03	13	147	2	C0002889
Disease	Microangiopathic hemolytic anemia	ITPA G6PD	1.85e-03	13	147	2	C0221021
Disease	Thrombosis	ADAMTS13 KLKB1 PROS1	1.89e-03	49	147	3	C0040053
Disease	anemia (is_implicated_in)	ITPA G6PD	2.16e-03	14	147	2	DOID:2355 (is_implicated_in)
Disease	hepatocellular carcinoma (is_implicated_in)	TRAF7 CALR EFTUD2 FUBP1 ARID2	2.18e-03	181	147	5	DOID:684 (is_implicated_in)
Disease	Ciliopathies	MYO7A CDH23 NEK1 DNAH5	2.27e-03	110	147	4	C4277690
Disease	cancer (implicated_via_orthology)	PARVB TRIP12 NDC80 MACF1 STX7 ALK	2.31e-03	268	147	6	DOID:162 (implicated_via_orthology)
Disease	infant head circumference	STRBP IGF2BP3	2.48e-03	15	147	2	EFO_0004577
Disease	Metastatic melanoma	PDGFRA ITK STRADB	2.49e-03	54	147	3	C0278883
Disease	primary autosomal recessive microcephaly (is_implicated_in)	BUB1 KNL1	2.83e-03	16	147	2	DOID:0070296 (is_implicated_in)
Disease	a disintegrin and metalloproteinase with thrombospondin motifs 13 measurement	ADAMTS13 KLKB1	3.19e-03	17	147	2	EFO_0008011
Disease	melanoma	MC1R DEF8 EYS KDSR	3.70e-03	126	147	4	EFO_0000756
Disease	urate measurement, bone density	QRICH1 CLIP1 PPL AKAP12 FSIP2 EYS RHOBTB1 RHOBTB2 USP40	3.96e-03	619	147	9	EFO_0003923, EFO_0004531

Protein segments in the cluster

Peptide	Gene	Start	Entry
QVVTLLVNRKCQIDV	ANKRD20A1	81	Q5TYW2
AKQLVSRVVTQNICQ	CCAR2	741	Q8N163
CIEASVKQEVLINRN	CATSPERG	806	Q6ZRH7
KHCENITKQVEIAVQ	CEP152	846	O94986
EVDKVNQIINNCIDA	ELFN1	561	P0C7U0
LQEKVQAVCADVEKS	ABRAXAS2	216	Q15018
ILEDKENVVAKQCTQ	BUB1	621	O43683
DEQVACQEVKVSVAI	AKAP12	1516	Q02952
QVVTLLVNRKCQIDV	ANKRD20A4P	81	Q4UJ75
CEVVKATVIQNSIPQ	ARID2	711	Q68CP9
QKVEVLCELVNDENV	AP4B1	331	Q9Y6B7
RTALIKAVQCQEEVC	ANKRD62	106	A6NC57
NIQVKCEDTVEKLQA	ANKRD62	806	A6NC57
AVVVANDIKCEAQQE	SPECC1	731	Q5M775
QVAEELQQVESCAVT	AASDH	461	Q4L235
ITHEGCEKVVVQNNL	CER1	171	O95813
NSVQVVIQVLDVNDC	CDH23	2491	Q9H251
AVVEEIQCLVQELKN	CFAP44	1226	Q96MT7
LDQARKELVETVQCQ	ADAMTS13	711	Q76LX8
VVAVLLQECKQVLDQ	ALPK1	6	Q96QP1
EQTTCQEVVIALAQA	RASSF7	26	Q02833
CVVDVEVFTNQEVKE	RCAN2	16	Q14206
VCTNLLIKQVVEVAC	RCBTB1	121	Q8NDN9
QTIKQGICEENAIAL	RCBTB2	481	O95199
ALEVFKQQVDNVAQC	PSTPIP2	76	Q9H939
LQVTCSAQTVQVAEV	QRICH1	441	Q2TAL8
VLKCISEVQANNVVL	G6PD	291	P11413
AVLQQLDNVIDVITC	MC1R	111	Q01726
QVVTLLVNRKCQIDV	ANKRD20A2P	81	Q5SQ80
IVVTCAVFNNEVVDL	PDGFRA	231	P16234
KCTVLIQVIDVNDHA	PCDHB13	331	Q9Y5F0
VVILQGVQCEVQLVE	IGHV3-72	11	A0A0B4J1Y9
LVQCVDAFEEKANIV	MYLK	1521	Q15746
VAIIKGVQCQVQLVE	IGHV3-11	11	P01762
ILESEKCQLQSQVEQ	MAFA	281	Q8NHW3
VKNFTGCIEVIEINN	EYS	2031	Q5T1H1
EDENIEICSKIVQNI	NEK1	1216	Q96PY6
EQISRIQQESGCKIQ	FUBP1	121	Q96AE4
EAVVIKESQNVDFIC	IBTK	831	Q9P2D0
KESQNVDFICSVLVV	IBTK	836	Q9P2D0
QNCLQEKVTSEELNI	FSIP2	496	Q5CZC0
AKIVNIVLCAIQNEL	FSIP2	1296	Q5CZC0
EEVQFTTVLCSKIQQ	FHIP2B	151	Q86V87
EIASREQEVQKICAN	PPL	776	O60437
KENEICVSQGEVVQV	KALRN	2336	O60229
LQCINVAVAQAKERE	VEPH1	811	Q14D04
NSCVQEIAEKQALAV	KNL1	1231	Q8NG31
LNTCVEISVQVEESQ	OVOS2	806	Q6IE36
DITVILNAVNAECQK	DDX31	401	Q9H8H2
QQRNITTVVEKLQLC	EXOC6	121	Q8TAG9
CQVAQRKIQEILTQV	IGF2BP3	546	O00425
DDNIQIGREVKISCQ	MDGA2	346	Q7Z553
AQIEKQEGIEVCALQ	MACF1	2776	Q9UPN3
NKIVIQDEIQNCIVT	ETAA1	486	Q9NY74
CKLNVAEVTQSEIGQ	PARVB	131	Q9HBI1
ENVKFIVNVRDICNE	PASD1	126	Q8IV76
VLCTAQVQVVTQDER	CD200	26	P41217
RSVIEICQEVIKQSN	PATZ1	146	Q9HBE1
ICQEVIKQSNVQILV	PATZ1	151	Q9HBE1
GQAVANVIDENVKLC	IL1RL2	431	Q9HB29
QQDQCVEITEESKAL	DCTN3	136	O75935
QVVTLLVNRKCQIDV	ANKRD20A3P	81	Q5VUR7
KDETKTQAIVCQQLD	ABCE1	191	P61221
LVANNEVCVKLVADA	KLHL11	311	Q9NVR0
KEVNVRGTDNILQVC	SDR42E1	96	Q8WUS8
VEVLSVIAVQVKCVQ	DNAH17	1906	Q9UFH2
VIAVQVKCVQDAIRA	DNAH17	1911	Q9UFH2
NICQQVNIKSLEDVV	EIF3A	76	Q14152
VGQVTCQKQALEEQL	CROCC2	721	H7BZ55
EELKQSVQQLRCTEA	FER	361	P16591
LVVQFTVKHEQNIDC	CALR	91	P27797
TVFTEIQIQIKENLC	DNAI7	521	Q6TDU7
IVVSNCVINLVPDKQ	AS3MT	151	Q9HBK9
VQEVDTVEICGALKN	GPD1	191	P21695
KEVIQELNNCQVTVA	MARF1	401	Q9Y4F3
VVEESVCNLLNTEVQ	CDCA2	516	Q69YH5
SDVQQLRQAIEECKQ	DEF8	141	Q6ZN54
EISIQKCQEAVRQVQ	ITPA	51	Q9BY32
ELNVTFVKGVNVCQE	KLKB1	306	P03952
VEHQCQKTIQQLETV	HEATR1	2121	Q9H583
IEVGEKNAACNILVN	EML5	1676	Q05BV3
VQVVEDICLLNIQGK	EMILIN2	546	Q9BXX0
KLAEVLVGEQQQCQD	HAUS4	201	Q9H6D7
DINCTKVLQGDVNEI	GCNT1	56	Q02742
QEVCKLQEQLEATVK	SASS6	441	Q6UVJ0
INDKQVVLCISVDVS	KDSR	81	Q06136
EVLQAKCNEQTKVID	CLIP1	746	P30622
ALEDVQQTLNKAVEC	DNAH5	1026	Q8TE73
NQQIQVVGLQEKEVC	KIF2B	381	Q8N4N8
LVVNKVESECVLNQQ	PRR14L	641	Q5THK1
ICQDVENLQKFVKEQ	NUP58	251	Q9BVL2
VAISKGVQCEVQLVE	IGHV3-53	11	P01767
EEQIISLVNQICGKV	JARID2	1186	Q92833
KCTVLIQVIDVNDHA	PCDHB8	331	Q9UN66
RNCLVGENQVIKVSD	ITK	486	Q08881
EEQCVQRLVAIASKE	MROH2A	116	A6NES4
VEVEQVANEKLCSDV	GUCY1A2	266	P33402
FAVEEIIQKQVKVNC	LXN	56	Q9BS40
IIQKQVKVNCTAEVL	LXN	61	Q9BS40
QQKVTADTQIVVCLL	PIWIL1	546	Q96J94
DKNETQKTCQVLIID	FREM3	1956	P0C091
CDQVQKVQVELTVLD	SYT5	316	O00445
NVINEKCITQNSETI	SLC6A15	361	Q9H2J7
TCDQVVLVVKEVINR	PRUNE2	341	Q8WUY3
VQVKDDQEAILTQFC	SH3BP4	591	Q9P0V3
NRQLQINVDCTLKEV	TAB3	581	Q8N5C8
QVDVVITCTGNKNVV	AHCYL1	366	O43865
NIQKITQCSVEIQRT	STX7	21	O15400
VPVIIIKQEEACQCQ	MTF1	621	Q14872
KEIIVINTAVACSNN	FYB2	661	Q5VWT5
TEKEQQIETVCETIQ	SMG1	3391	Q96Q15
CETIQNLVDNIKTVL	SMG1	3401	Q96Q15
NVETIKCVVVGDNAV	RHOBTB2	11	Q9BYZ6
QCVDRQEVAEITKQL	TCAP	126	O15273
QCVNEASIIIRNTKE	STRBP	141	Q96SI9
NVETIKCVVVGDNAV	RHOBTB1	11	O94844
TSTKVCEFENQVVIL	STARD9	1861	Q9P2P6
IIQEKQNKHCLVTVE	PROS1	466	P07225
NQSVREVTQIKCIEL	P2RY14	161	Q15391
NKTVTACQILQRVED	STARD3	311	Q14849
QVAVQQVDLCTIQAV	ERVK-9	661	P63128
QKVCIGENNVIEEEI	ALK	791	Q9UM73
KGQVLSVCVEEDNIV	CLTCL1	321	P53675
CQEVRAQLVVIKTAE	CLEC4M	296	Q9H2X3
QQLVSDCVKELRETN	TRAK2	246	O60296
TRAQCVTVKENLLEQ	RWDD3	76	Q9Y3V2
KCIVNNVSAETVQTV	SPART	561	Q8N0X7
QLCAQVQEDTIKVAV	TTLL8	556	A6PVC2
CQQEEVKQEITATLE	XPO4	796	Q9C0E2
QTVEEGSNVKLVCNV	TMIGD1	131	Q6UXZ0
QLIDITGKNQDECVI	UBAP2L	56	Q14157
VCISEKQENDVINAI	RALGAPA1	1711	Q6GYQ0
TQLVEQFKCLEQQSE	SRGAP3	26	O43295
VNCQERKIESIAELQ	SLITRK5	391	O94991
ECQAVNIIGSQKVVA	PXDN	501	Q92626
CPVDNVKLTVVVNNI	TRAF7	161	Q6Q0C0
LSCQKETQLVDKIVQ	S100Z	46	Q8WXG8
TNVLNIANEDCIKVA	TENM3	2511	Q9P273
IANEDCIKVAAVLNN	TENM3	2516	Q9P273
IVCNEKNNIAEIKIQ	VPS13C	1096	Q709C8
DSTCQIAQEIAEKIQ	STX8	11	Q9UNK0
VCAKIVQLLGQNEVD	UCK2	36	Q9BZX2
EICDVHVNSEIQLKQ	ZNF385B	351	Q569K4
VEAQVIFQLRAKQCV	UNKL	626	Q9H9P5
RVDSAEVQKVCNICV	UBE3B	451	Q7Z3V4
VTIKITNLENCNEER	STRADB	86	Q9C0K7
AVVGQECEVQIVFKN	TGM1	701	P22735
QVVCALINLVIAQVQ	USP34	61	Q70CQ2
IQKLNRTVVANEICE	THSD7B	146	Q9C0I4
AVQERLAVTVCINKI	EFTUD2	246	Q15029
QQRNCTEGIVIKTEE	ZNF777	441	Q9ULD5
QVIQCIDVAEQALTA	TRIP12	531	Q14669
IVNQIVCKECKNVSE	USP40	166	Q9NVE5
VSQEICDGVLKNQQL	UGT2A1	121	P0DTE4
GINIICEIVDKQNTI	ZFYVE16	591	Q7Z3T8
TKCQRDNIEETLVNI	ZNF487	396	B1APH4
NIIKQCVINKVSQTE	VPS54	411	Q9P1Q0
VDKVNQIINNCIDAL	ELFN2	541	Q5R3F8
EVQLQQKVCDTLQGE	GOLGB1	2271	Q14789
AVVKLCDSGQVQVVD	MYO7A	26	Q13402
QVEVEAAEQNVSRIC	MYO7B	1786	Q6PIF6
ECETIKQENTRLQNI	NDC80	341	O14777